Medicine
Biorphen 10 mg/1 mL injection
Biorphen 10 mg/1 mL injection is a prescription medicine containing Phenylephrine for intravenous use, marketed by Dr. Reddy's Laboratories, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store BIORPHEN (phenylephrine hydrochloride) injection at 20°C to 25°C (68°F…
Key facts
- Active ingredient (INN)
- Phenylephrine
- Brand
- Biorphen
- Strength
- 10 mg/1 mL
- Dosage form
- Injection
- Route
- Intravenous
- Packs
- 10 ampules of 1 mL
- Marketing authorisation holder
- Dr. Reddy's Laboratories
- Manufacturer
- Dr. Reddy's LaboratoriesIndia
- Origin register
- US FDA, United States
- Storage
- Store BIORPHEN (phenylephrine hydrochloride) injection at 20°C to 25°C (68°F to 77°F), excursions permitted to 15°C to 30°C (59°F to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C01CA06 Phenylephrine
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 25 November 2022
- Identifiers
- RxCUI 1666372, 2262018, 2533434 +1DailyMed set ID 2f715e4e-b269-b935-d2c9-003cb29770beNDC 43598-199Application NDA212909
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 ampule in 1 carton / 1 mL in 1 ampule | 43598-199-10 | Dr. Reddy's LaboratoriesIndia | 25 November 2022 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 20 December 2012 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Phenylephrine 10 mg/1 mL injection.
Other strengths and forms of Phenylephrine
Clinical summary
Phenylephrine is an alpha-1 adrenergic agonist indicated for increasing blood pressure in adults with clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia, among other approved uses. MedsAcross supplies Phenylephrine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PhenylephrineFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Phenylephrine Hydrochloride prescribing information (Hikma Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
Need Biorphen 10 mg/1 mL injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.